Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

PRIME PHARMACEUTICALS PRIVATE LIMITED

Active

PRIME PHARMACEUTICALS PRIVATE LIMITED having CIN U24231MH1995PTC092543 is 29 years , 9 month & 11 days old Private Indian Company incorporated on 11 Sep 1995. It is classified as Non-government company and is registered at ROC Mumbai. Its authorized share capital is Rs. 20,000,000 and its paid up capital is Rs. 5,998,800. It's NIC code is 24231 (which is part of its CIN).

As per the NIC code, it is involved in Manufacture Of Chemical Substances Used In The Manufacture Of Pharmaceuticals: Antibiotics . PRIME PHARMACEUTICALS Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-30-2023. Directors of PRIME PHARMACEUTICALS are Irfan Vazirally and Ashish Anil Vora.

PRIME PHARMACEUTICALS ' Corporate Identification Number (CIN) is U24231MH1995PTC092543 and its registration number is 092543. Users may contact PRIME PHARMACEUTICALS on its Email address - mumbai@primepharma.co.in Registered address of PRIME PHARMACEUTICALS is B327/328, 3rd Floor, Chintamani Plaza, Andheri Kurla Road, Andheri East,,Mumbai,Maharashtra,India-400099. Current status of PRIME PHARMACEUTICALS PRIVATE LIMITED is - Active.

Key Indicators

Authorised Capital
20,000,000

as on 22/06/2025

Paid Up Capital
5,998,800

as on 22/06/2025

Company Age
29 Year, 9 Months
Last Filing with ROC
1 Year, 8 Months

Company Information

CIN U24231MH1995PTC092543
Company Status Active
Registration Number 092543
Date of Incorporation 09/11/1995
RoC ROC Mumbai
Company Age 29 years & 292 days
Authorized Capital ₹ 20000000
Paid-up capital ₹ 5998800
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Private
Activity Manufacture Of Chemical Substances Used In The Manufacture Of Pharmaceuticals: Antibiotics
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2023
Date of Latest Balance Sheet 31-03-2023

Contact

Email ID mumbai@primepharma.co.in
Address 5-SUKH SHANTI, NS ROAD NO. 8, NUTAN LAXMI SOC, JVPD SCHEME MUMBAI Maharashtra India 400049
Website primepharma.co.in
Contact Number +91*******

Location on Map

Director

DIN Name Date OF Appointment Designation Tenure
01555238
ASHISH ANIL VORA
19 May 2023 Director 29 years
02498588
MANISH PATEL
02 Apr 1998 Director 29 years
01029447
DEVANG SUBODH THAKAR
06 Feb 2023 Director 29 years
01187443
ANIL KUMAR VORA
11 Sep 1995 Director 29 years
00446203
RAMAMURTHY AYYAVUTHEVAR
18 Apr 2023 Director 29 years
02491422
IRFAN VAZIRALLY
07 Mar 2024 Director 29 years
08390366
MANISH NAVNITRAI VORA
31 May 2024 Director 29 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
BHARTI LIFE SCIENCES PRIVATE LIMITED.
Amalgamated
1,58,47,500.00 2 Maharashtra
QUEEN PHARMACEUTICALS LIMITED
Amalgamated
1,31,22,000.00 2 Tamil Nadu

Charges on assets

1

CITI BANK N.A.

No. of Loans: 1

Total Amount: 300,000,000.00 cr

2

Others

No. of Loans: 3

Total Amount: 117,500,000.00 cr

3

ING VYSYA BANK LIMITED

No. of Loans: 1

Total Amount: 30,000,000.00 cr

4

The Saraswat Co-op Bank Ltd

No. of Loans: 6

Total Amount: 6,775,000.00 cr

5

THE SARASWAT CO-OPRATIVE BANK LTD.

No. of Loans: 5

Total Amount: 19,200,000.00 cr

Charge Holder Branch Amount Date of creation Modification Satisfaction Status
CITI BANK N.A. Bandra Kurla Complex, Bandra (East) 300,000,000 18 May, 2023 15 Apr, 2024 - Open
Others Old Padra Road 105,000,000 06 May, 2017 12 Apr, 2022 20 Jun, 2023 Closed
ING VYSYA BANK LIMITED KRISHNA KUNJ,PLOT NO.32,10TH NORTH SOUTH ROAD,JUHU 30,000,000 28 Oct, 2009 - 17 Apr, 2017 Closed
Others Old Padra Road 5,000,000 17 Jul, 2021 - 20 Jun, 2023 Closed
Others Old Padra Road 7,500,000 25 May, 2021 - 20 Jun, 2023 Closed
The Saraswat Co-op Bank Ltd 450,000 05 Mar, 2007 - 04 May, 2009 Closed
The Saraswat Co-op Bank Ltd 2,500,000 17 May, 2006 - 04 May, 2009 Closed
THE SARASWAT CO-OPRATIVE BANK LTD. MADHUSAGAR; N. S. ROAD NO. 13 10,000,000 18 Jul, 2000 09 Sep, 2004 04 May, 2009 Closed
The Saraswat Co-op Bank Ltd 1,200,000 14 Sep, 2007 - 04 May, 2009 Closed
The Saraswat Co-op Bank Ltd 1,200,000 26 Nov, 2007 - 04 May, 2009 Closed
THE SARASWAT CO-OPRATIVE BANK LTD. MADHUSAGAR; N. S. ROAD NO. 13 1,500,000 15 Apr, 2004 - 04 May, 2009 Closed
THE SARASWAT CO-OPRATIVE BANK LTD. MADHUSAGAR; N. S. ROAD NO. 13 1,500,000 28 Mar, 2003 - 04 May, 2009 Closed
THE SARASWAT CO-OPRATIVE BANK LTD. MADHUSAGAR; N. S. ROAD NO. 13 3,000,000 30 Mar, 2001 16 Sep, 2004 04 May, 2009 Closed
THE SARASWAT CO-OPRATIVE BANK LTD. MADHUSAGAR; N. S. ROAD NO. 13 3,200,000 16 Sep, 2002 - 04 May, 2009 Closed
The Saraswat Co-op Bank Ltd 1,250,000 29 Jan, 2007 - 04 May, 2009 Closed
The Saraswat Co-op Bank Ltd 175,000 09 Feb, 2007 - 04 May, 2009 Closed

Registered Details

CIN
U24231MH1995PTC092543
Incorporation
29 years , 9 month
Company Email
mumbai@primepharma.co.in
Paid up Capital
₹ 5,998,800
Authorised Capital
₹ 20,000,000
Type
Private Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Industry

Manufacture Of Chemical Substances Used In The Manufacture Of Pharmaceuticals: Antibiotics

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 0.00%
₹ 0
EBITDA arrow 0.00%
₹ 0
Net Profit arrow0.00%
₹ 0
Networth arrow0.00%
₹ 0
Borrowings arrow0.00%
₹ 0
Assets arrow0.00%
₹ 0
Gross Margin arrow0.00%
₹ 0
Operating Margin arrow0.00%
₹ 0
Net Profit Margin arrow0.00%
₹ 0
Return on Equity arrow0.00%
₹ 0
ROCE arrow9.29%
₹ 140,987.4
Debt to Equity arrow0.00%
₹ 0

Financial Highlights

** All numbers in INR

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capital
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

Profit & Loss

**** All numbers in INR

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Solvency 0.00 0.00 0.00 0.00 0.00
Total Debt/Equity 0.00 0.00 0.00 0.00 0.00
Total Debt/Assets 0.00 0.00 0.00 0.00 0.00
Total Assets/Equity 0.00 0.00 0.00 0.00 0.00
Liquidity 0.00 0.00 0.00 0.00 0.00
Current Ratio 0.00 0.00 0.00 0.00 0.00
Quick Ratio 0.00 0.00 0.00 0.00 0.00
Interest Coverage 0.00 0.00 0.00 0.00 0.00
Performance 0.00 0.00 0.00 0.00 0.00
Gross Margin 0.00 0.00 0.00 0.00 0.00
Operating Margin 0.00 0.00 0.00 0.00 0.00
Net Margin 0.00 0.00 0.00 0.00 0.00
Return 0.00 0.00 0.00 0.00 0.00
Return on Equity 0.00 0.00 0.00 0.00 0.00
Pre-tax ROCE 0.00 0.00 0.00 0.00 0.00
Return on Assets 0.00 0.00 0.00 0.00 0.00
Pre-tax ROIC 0.00 0.00 0.00 0.00 0.00
Efficiency 0.00 0.00 0.00 0.00 0.00
Days Payable 0.00 0.00 0.00 0.00 0.00
Days Inventory 0.00 0.00 0.00 0.00 0.00
Days Receivable 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover 0.00 0.00 0.00 0.00 0.00
Total Asset Turnover 0.00 0.00 0.00 0.00 0.00
Working Capital 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle 0.00 0.00 0.00 0.00 0.00
Working Capital Days 0.00 0.00 0.00 0.00 0.00
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Prime Pharmaceuticals Private Limited

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Prime Pharmaceuticals Private Limited

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Prime Pharmaceuticals Private Limited

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Purpose of passing the resolution Subject Matter of Resolution Resolution Agreed By Special Resolution Address

Auditors of Prime Pharmaceuticals Private Limited

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number Registration Number Address

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Prime Pharmaceuticals Private Limited

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Prime Pharmaceuticals Private Limited

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Prime Pharmaceuticals Private Limited

What is PRIME PHARMACEUTICALS PRIVATE LIMITED ?

PRIME PHARMACEUTICALS PRIVATE LIMITED having CIN U24231MH1995PTC092543 is 29 years , 9 month old Private Indian Company incorporated with MCA on 31 May 2024. PRIME PHARMACEUTICALS PRIVATE LIMITED is listed in the class of Private Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Mumbai with an Authorized Share Capital of 20,000,000 and paid-up capital is 5,998,800.

What is the CIN of PRIME PHARMACEUTICALS PRIVATE LIMITED?

CIN of PRIME PHARMACEUTICALS PRIVATE LIMITED is U24231MH1995PTC092543.

Where is PRIME PHARMACEUTICALS PRIVATE LIMITED located?

Address of PRIME PHARMACEUTICALS PRIVATE LIMITED is B327/328, 3rd floor, chintamani plaza, andheri kurla road, andheri east,,mumbai,maharashtra,india-400099,.

Who are the directors of PRIME PHARMACEUTICALS PRIVATE LIMITED ?

The company has 12 directors/key management personnel Ashish Vora,manish Patel,devang Thakar,anil Kumar Vora,ramamurthy Ayyavuthevar,devang Thakar,irfan Vazirally,ramamurthy Ayyavuthevar,manish Vora,irfan Vazirally,ashish Vora,u24231mh1995ptc092543 U24231mh1995ptc092543,

What is the contact details of PRIME PHARMACEUTICALS PRIVATE LIMITED ?

Email : mumbai@primepharma.co.in
Address : 5-SUKH SHANTI, NS ROAD NO. 8, NUTAN LAXMI SOC, JVPD SCHEME MUMBAI Maharashtra India 400049

What does PRIME PHARMACEUTICALS PRIVATE LIMITED do?

PRIME PHARMACEUTICALS PRIVATE LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing

Popular Search

Top Companies in your State

Enquiry